Quarterly report · Q3
4323.TEDINET S100Q74J
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥914m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥919m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥15.6bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥13.8bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.8bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.7bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥482m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥352m | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥73m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥276m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥515m | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥95.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.07 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.46 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.4% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥143m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥143m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.2bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥35m |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥277m |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥171m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥42m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥737m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥16.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥16.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥66m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥66m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥1.1bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥12m |
| jpcrp040300-q3r_E05236-000Global Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥39m |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥211m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3m |
| jpcrp040300-q3r_E05236-000Package Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥965m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥66m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 2691000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 12075000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 65945000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -65945000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 9448990000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 3027337000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1137571000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 1438035000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 15051934000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -65945000 | JPY |
| Net sales | Prior1YTDDuration | 14985989000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 1214177000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 964738000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 210635000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 39264000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2428814000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1131603000 | JPY |
| Operating income | Prior1YTDDuration | 1297211000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 10392405000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 2996685000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1185412000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 2060715000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 16635219000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 16635219000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 65946000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 42200000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 35299000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 143446000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -143446000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 10458352000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 3038886000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1185412000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 2096015000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 16778665000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -143446000 | JPY |
| Net sales | CurrentYTDDuration | 16635219000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05236-000DXAndSIBusinessMember | 1614877000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05236-000PackageBusinessReportableSegmentMember | 736708000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 171071000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05236-000GlobalBusinessReportableSegmentMember | 277242000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2799900000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -1239948000 | JPY |
| Operating income | CurrentYTDDuration | 1559952000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |